Welcome to our dedicated page for Berto Acquisition SEC filings (Ticker: TACO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. Securities and Exchange Commission filings for Berto Acquisition Corp. (NASDAQ: TACO), a special purpose acquisition company organized in the Cayman Islands. As a blank check company with listed ordinary shares, units, and warrants, Berto uses SEC reports to disclose material events and provide information to shareholders and the market.
Among the notable filings is a Form 8-K dated October 29, 2025, in which Berto reports that it has entered into a non-binding letter of intent with OnMed LLC, described as a developer of healthcare infrastructure solutions. The Form 8-K furnishes a joint press release as an exhibit and explains that the letter of intent relates to a potential business combination. It also states that there can be no assurances that a definitive agreement will be reached or that any transaction will be consummated, and it outlines the need for due diligence, negotiation of definitive terms, board and equity holder approvals, regulatory approvals, and other customary conditions.
How this filings page helps
Through this page, users can access Berto’s current and historical SEC submissions, including Forms 8-K and other reports referenced in the company’s disclosures. These filings provide details on Berto’s capital structure, such as its Nasdaq-listed ordinary shares (TACO), units (TACOU), and warrants (TACOW), and describe how any proposed business combination may be presented to shareholders.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents in plain language. For example, when Berto files a Form 8-K about a transaction, AI-generated highlights can point out the nature of the event, the parties involved, and the conditions that must be satisfied. When registration statements or proxy statements/prospectuses are filed in connection with a potential business combination, AI tools can help readers understand the structure of the deal, voting mechanics, and risk disclosures without having to parse every page.
In addition, this page provides convenient access to exhibits referenced in Berto’s filings, such as the joint press release attached to the October 29, 2025 Form 8-K. Investors can use these documents to review forward-looking statements, understand the company’s cautionary language, and see how Berto describes the interests of its directors and officers in any proposed transaction.
Berto Acquisition Corp. filed its quarterly report for the period ended September 30, 2025. The SPAC reported net income of $3.17 million for the quarter and $5.01 million year-to-date, driven primarily by interest earned on funds in its trust.
The company completed its IPO on May 1, 2025, selling 30,015,000 units at $10.00 for gross proceeds of $300.15 million, with approximately $17.8 million in offering costs, including $11.7 million of deferred underwriting commissions. As of September 30, 2025, the trust account held $305,577,225 (reflecting accretion to $10.18 per redeemable share). Cash held outside the trust was $325,010 with working capital of approximately $216,000.
There were 37,518,750 ordinary shares outstanding as of November 13, 2025, including 30,015,000 Public Shares and 7,503,750 Founder Shares. Warrants outstanding comprised 15,007,500 public, 3,500,000 sponsor private placement, and 3,750,000 underwriter warrants, with an exercise price of $10.50 in the first 12 months after a business combination and $11.50 thereafter. The completion window extends to May 1, 2027. On October 29, 2025, the company announced a non-binding LOI with OnMed LLC.
Berto Acquisition Corp. said it has signed a nonbinding letter of intent to combine with OnMed LLC, a company that designs and operates portable 8-by-10-foot CareStations that blend telemedicine with clinic tools like a stethoscope, blood pressure monitor, scale, and infrared camera.
OnMed operates under contracts in seven states and Puerto Rico. CEO Karthik Ganesh, who would lead the combined company, said the stations can be deployed in 30 days and have fully diagnosed 85% of patients without specialist referral, while supporting the 50% of patients who said they would otherwise have gone to the ER or urgent care.
Berto, the 10th SPAC sponsored by Harry You, raised $300 million including overallotment shares in an April IPO. The announcement comes amid a stronger SPAC market, with 108 U.S. SPACs raising more than $22 billion this year and 59 merger deals announced since Jan. 1.
Berto Acquisition Corp. (TACO) announced a non-binding letter of intent with OnMed LLC for a potential business combination. The companies jointly disclosed the LOI via a Form 8-K and press release. The LOI does not obligate either party to complete a deal.
Any transaction would require completion of due diligence, negotiation and execution of a definitive agreement, board and equity holder approval, regulatory approvals, and other customary closing conditions. The disclosure was furnished under Item 7.01, meaning it is not deemed filed for liability purposes under Section 18.
If a definitive agreement is reached, a registration statement including a proxy statement/prospectus would be prepared and mailed to Berto shareholders. The filing also includes standard forward‑looking statements and cautions that there can be no assurances the transaction will be consummated.
Berto Acquisition Corp. announced that it and OnMed LLC entered into a non-binding letter of intent on
The LOI does not guarantee a deal. Any transaction would require completion of due diligence, negotiation and execution of a definitive agreement, satisfaction of agreed conditions, board and equity holder approvals, regulatory approvals, and other customary steps. The companies also cautioned that timing and terms may change or the transaction may not occur.
The disclosure was furnished under Item 7.01 and not deemed filed. If a definitive agreement is signed, Berto or a newly formed holding company will prepare and file a registration statement that includes a proxy statement/prospectus with the SEC, which would be mailed to Berto’s shareholders.